18-46566443-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001384474.1(LOXHD1):c.2251C>T(p.Arg751Trp) variant causes a missense change. The variant allele was found at a frequency of 0.000818 in 1,549,294 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. R751R) has been classified as Likely benign.
Frequency
Consequence
NM_001384474.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LOXHD1 | NM_001384474.1 | c.2251C>T | p.Arg751Trp | missense_variant | 17/41 | ENST00000642948.1 | NP_001371403.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LOXHD1 | ENST00000642948.1 | c.2251C>T | p.Arg751Trp | missense_variant | 17/41 | NM_001384474.1 | ENSP00000496347 | P1 | ||
LOXHD1 | ENST00000536736.5 | c.2251C>T | p.Arg751Trp | missense_variant | 17/40 | 5 | ENSP00000444586 | |||
LOXHD1 | ENST00000441551.6 | c.2251C>T | p.Arg751Trp | missense_variant | 17/39 | 5 | ENSP00000387621 | |||
LOXHD1 | ENST00000335730.6 | n.1564C>T | non_coding_transcript_exon_variant | 10/27 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000559 AC: 85AN: 152172Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000538 AC: 84AN: 156082Hom.: 0 AF XY: 0.000582 AC XY: 48AN XY: 82426
GnomAD4 exome AF: 0.000847 AC: 1183AN: 1397004Hom.: 1 Cov.: 31 AF XY: 0.000808 AC XY: 557AN XY: 689058
GnomAD4 genome AF: 0.000558 AC: 85AN: 152290Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 26AN XY: 74466
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 77 Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 11, 2022 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Aug 15, 2017 | - - |
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 05, 2022 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 751 of the LOXHD1 protein (p.Arg751Trp). This variant is present in population databases (rs376539851, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of Fuchs corneal dystrophy (PMID: 22341973). ClinVar contains an entry for this variant (Variation ID: 47929). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects LOXHD1 function (PMID: 22341973). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 08, 2017 | - - |
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 07, 2020 | The p.Arg751Trp variant in LOXHD1 has been previously identified by our laboratory in four individuals with hearing loss; however a second variant in trans (on the other copy of the gene) was not identified in any of these individuals. This variant has been identified in 0.13% (12/8778) of Ashkenazi Jewish chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs376539851). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. The p.Arg751Trp variant has been seen in the heterozygous state in one individual with late-onset Fuchs corneal dystrophy (FCD); however the hearing status was not reported (Riazuddin 2012). This variant's association with FCD has not been reported in other affected individuals, which, given the frequency in the general population and presumed autosomal dominant inheritance pattern of FCD, does not support a strong correlation between this variant and FCD. It has also been reported in an individual with eosinophilic esophagitis, but the LOXHD1 gene has not been associated with this condition. Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Arg751Trp variant is uncertain. ACMG/AMP Criteria applied: None. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 16, 2024 | Variant summary: LOXHD1 c.2251C>T (p.Arg751Trp) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00054 in 156082 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in LOXHD1 causing Nonsyndromic Hearing Loss And Deafness, Type 77 (0.00054 vs 0.0011), allowing no conclusion about variant significance. c.2251C>T has been reported in the literature in at least one individual affected with Fuchs corneal dystrophy, however no further clinical information was provided (e.g. Riazuddin_2012). This report does not provide unequivocal conclusions about association of the variant with Nonsyndromic Hearing Loss And Deafness, Type 77. At least one publication reports experimental evidence evaluating an impact on protein function and found the variant resulted in cytoplasmic aggregates when expressed in retinal pigment epithelium cells (Riazuddin_2012); however, the clinical significance of this finding is currently unclear and does not allow convincing conclusions about the variant effect. The following publication has been ascertained in the context of this evaluation (PMID: 22341973). ClinVar contains an entry for this variant (Variation ID: 47929). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at